Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl–mediated drug resistanceJennifer S. Carew, John L. Cleveland, Chunying Yang et al.|Blood|2007Cited by 485
The FEN1 E359K germline mutation disrupts the FEN1–WRN interaction and FEN1 GEN activity, causing aneuploidy-associated cancersLinda H. Chung, Binghui Shen, David Miruka Onyango et al.|Oncogene|2014Cited by 29